University of Rochester Researcher Elected to Chair Genetics Section of the National Academy of Sciences

August 25, 1999

The National Academy of Sciences (NAS) has elected Fred Sherman, Ph.D., to its chair of Section 26, Genetics. Election to the academy is considered one of the highest honors that can be bestowed upon a scientist, and Sherman is currently the only scientist in the University of Rochester Medical Center to be a member of the NAS.

Fred Sherman is one of the scientific pioneers who studied yeast to develop important scientific and genetic principles, says Lowell Goldsmith, dean of the School of Medicine and Dentistry. The University is proud and pleased to be the institution where he performed these seminal scientific studies and led our department of biochemistry for over a decade and a half.

Participating in National Academy of Science matters is both enjoyable and fulfilling, and gives me wonderful opportunities to interact with many of my colleagues,says Sherman.

Sherman’s significant contributions to the area of yeast biology were recognized by his initial election to the National Academy of Sciences in 1985. Many of the genes that are necessary for human functions are present in yeast cells, making yeast an attractive organism on which to do genetic experiments.

As chair of Section 26, Genetics, Sherman will help nominate new members to the NAS as well as collect and distribute information for the Section 26 members. Sherman has been chair of the Department of Biochemistry, or the Department of Biochemistry & Biophysics of the University of Rochester from 1982 through 1999. He has published more than 200 articles on the molecular biology and genetics of yeast. He initiated a course on the molecular biology and genetics of yeast at the Cold Spring Harbor Laboratory in 1970, and was an instructor for 17 years. He is funded to do research in various areas of yeast biology, including gene expression, protein processing and degradation, mitochondrial import, chaperones, as well as studies with the pathogenic yeast Candida albicans.

For Media Inquiries:
Public Relations Department
(585) 275-3676
Email Public Relations